Simcere Subsidiary Gets Swine Flu Vaccine License
Stock quotes in this article:
SCR
NEW YORK (AP) — Chinese drugmaker Simcere Pharmaceutical Group said Tuesday that a company in which it owns a stake, Jiangsu Yanshen Biological Technology Stock Co., received a license to make a swine flu vaccine.
Jiangsu Yanshen received a new drug certificate and a production license from China's food and drug regulators on Friday, Simcere said. Simcere said it has a 37.5 percent stake in Jiangsu Yanshen, which is one of six Chinese flu vaccine makers with a license to make a swine flu vaccine.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.50 | 1,106.41 | 2,190.31 | 35.40 |
Oil *
71.66
|
|
UP
65.67
|
UP
4.06
|
DOWN
0.55
|
UP
0.58
|
10 Yr
3.54%
SPDR Gold
109.32
|
|
+0.63%
|
+0.37%
|
-0.03%
|
+1.67%
|
Data delayed 20 minutes |
